![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Riling Dave
Publisher: Future Medicine
ISSN: 1462-2416
Source: Pharmacogenomics, Vol.5, Iss.4, 2004-06, pp. : 347-349
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The changing face of acute medicine
By Connor Henry
Clinical Medicine, Vol. 2, Iss. 4, 2002-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The changing face of international medicine
Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The changing face of renal medicine in the UK
Clinical Medicine, Vol. 7, Iss. 2, 2007-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Smith A.
Trends in Pharmacological Sciences, Vol. 22, Iss. 1, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Changing Face of HDAC Inhibitor Depsipeptide
Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. :